Here, we show that the mutated CBP or EP300 in cells derived from RSTS patients compromise the integrity and functionality of the HSF pathway, thereby impacting the stability of the short-lived HSF2 protein. The gene discussed is EP300; the disease is Rubinstein-Taybi syndrome.